![]() |
市場調查報告書
商品編碼
1871878
全球細胞培養肉類和魚類市場:預測至2032年-按來源、產品形式、通路、技術、應用和地區進行分析Cell-Cultured Meat & Seafood Market Forecasts to 2032 - Global Analysis By Source (Poultry, Beef, Seafood, Pork, Duck and Exotic Meats), Product Format, Distribution Channel, Technology, Application and By Geography |
||||||
根據 Stratistics MRC 的一項研究,預計到 2025 年,全球細胞培養肉類和魚類市場價值將達到 3.9382 億美元,到 2032 年將達到 33.5425 億美元,在預測期內的複合年成長率為 35.8%。
細胞培養肉類和魚是一種利用在潔淨、可控的實驗室或工業環境中培養的活體動物細胞直接生產真正肉類的技術。無需飼養牲畜或捕撈魚類,細胞即可生長成肌肉和脂肪組織,複製傳統肉類的風味、營養和食用體驗。這種創新方法解決了氣候變遷影響、抗生素抗藥性、動物福利和全球魚類資源枯竭等關鍵問題。生物反應器、工程化生長因子和高效細胞培養系統的應用,使得細胞培養肉和魚類能夠穩定生產,不受季節和地理限制。人們對永續蛋白質日益成長的興趣,促使Start-Ups和大型食品公司積極投資該領域。自動化技術的進步、培養基成本的下降以及相關法規的支持,正逐步為細胞培養肉和魚的商業性化鋪路。
根據《生物工程雜誌》(2024)的報導,利用細胞培養技術生產水產品是滿足全球日益成長的魚類蛋白需求的可行替代方案,目前魚類蛋白佔動物蛋白消費量的17%。鑑於目前90%的海洋魚類資源捕撈量已超過永續水平,細胞培養水產養殖提供了一個永續的解決方案。
對永續蛋白質的需求日益成長
環境永續性是推動細胞培養肉類和魚類產業擴張的重要因素。傳統畜牧業和海洋捕撈會導致排放增加、棲息地喪失、水污染和過度捕撈。相較之下,細胞培養蛋白的生產只需佔用極少的土地,用水量較少,碳足跡也顯著降低。這項技術得到了具有氣候意識的消費者、企業和政策制定者的支持,他們都在尋求建立更環保的食品體系。在國際社會致力於永續性和排放碳排放的推動下,各國政府和投資者正在資助生物反應器、培養基和可擴展生產工廠的創新。人們對生態系統破壞的日益關注,正在推動對清潔、負責任的蛋白質來源的需求,進而促進市場發展。
生產成本高且擴充性有限
限制市場擴張的關鍵因素是高成本和複雜的生產流程。培養肉依賴昂貴的生長因子、細胞株、工業生物反應器和受控設施,這顯著增加了營運成本。此外,它還需要專業的科學家和工程師,這推高了人事費用。儘管新的方法正在降低成本,但許多國家仍然缺乏大規模生產所需的生物製造基礎設施。商業化生產仍面臨挑戰,零售價格也高於傳統動物性蛋白質。如果沒有價格合理的原料、簡化的工藝流程和穩健的供應鏈,培養肉產品很可能仍將局限於小規模規模試點和專賣店,而無法進入更廣泛的食品市場。
生物製程的進步與成本的降低
持續的技術進步為培養肉生產商帶來了強大的商業性優勢。改良的培養基配方、最佳化的生物反應器和經濟高效的支架材料減少了對昂貴原料的依賴,並降低了營運成本。透過自動化、機器人技術和數位化監控簡化生產過程,提高了產品的均勻性、安全性和風味可重複性。研究機構和Start-Ups正在設計擴充性的工作流程,以提高細胞產量和改善質地,同時降低成本。隨著生產系統的日益完善,預計零售價格將逐步接近傳統肉品的價格。與大型食品公司、大學和原料供應商的合作正在幫助建立全球供應鏈網路。這些進步將使培養蛋白更具競爭力,並得到更廣泛的應用。
來自植物性產品和傳統肉品的競爭
培養肉公司身處競爭激烈的市場,植物性和傳統肉品佔據了商店地位。植物性品牌擁有大規模生產、低價格和較高的消費者認知度,因此進入門檻較低。同時,傳統肉類價格實惠、接受度高,並有龐大的農業產業支持。如果培養肉產品無法在成本、口味熟悉度和供應方面與之競爭,消費者可能會繼續選擇他們現有的蛋白質來源。大型肉類公司也不斷提高其永續性標準,並積極推廣其環保舉措,這降低了消費者轉向人造肉的緊迫性。這種競爭可能會限制培養肉的成長前景,並延緩其被主流市場接受的過程。
感染疾病為培養肉產業帶來了挑戰與機會。傳統肉類生產面臨供不應求、污染風險和工廠臨時關閉等問題,促使消費者尋求更安全、更衛生的蛋白質來源。這種轉變使得培養肉和魚貝類獲得了更多資金籌措和政策關注。同時,旅行限制和實驗室關閉也延緩了實驗測試、設備交付和規模化生產計劃。疫情初期,Start-Ups新創企業面臨營運成本上升和投資者信心下降的困境。然而,疫情也凸顯了可控、無病害生產系統的優勢。因此,培養肉作為一種具有韌性和安全保障的食品解決方案,獲得了長期認可。
預測期內,家禽市場將佔據最大的市場佔有率。
預計在預測期內,禽肉領域將佔據最大的市場佔有率,因為雞肉是一種廣受歡迎且用途廣泛的蛋白質來源,深受各地消費者的喜愛。與更複雜的肉類相比,培養禽肉細胞生長效率更高,技術挑戰更少,從而能夠順利實現規模化生產並確保產品品質的一致性。許多新興企業已推出雞肉原型產品,包括一口大小、條狀和混合型等多種形式,以適應現有的菜單和烹飪方法。此外,注重營養的消費者尋求更輕盈的動物性蛋白質替代品,也進一步推動了該領域的發展。食品品牌和快餐店熱衷於試用培養雞肉,預計這將加速其商業化進程,並提高主流市場的認知度。因此,與其他培養肉類別相比,禽肉預計將繼續保持領先地位。
預計寵物食品細分市場在預測期內將呈現最高的複合年成長率。
預計在預測期內,寵物食品產業將呈現最高的成長率,這主要得益於消費者對寵物健康安全營養日益成長的需求。許多飼主正在摒棄傳統產品和來源不明的肉類,轉而選擇透明且不傷害動物的原料。培養蛋白消除了污染風險,避免了使用抗生素,使其成為一種高階替代品,符合寵物人性化趨勢。眾多創新者正在研發犬貓的細胞培養食品和零食,推動了該品類的快速擴張。動物食品的核准流程通常比人類產品更為簡便,這使得企業能夠更快地將產品推向市場,從而有望實現強勁的複合年成長率。
北美預計將在整個預測期內佔據最大的市場佔有率,這得益於其強大的科研生態系統、鼓勵創新的文化以及早期商業化活動。研究機構和領先的食品科技公司正在快速開發細胞株、生物反應器和混合產品形式,吸引了大量投資者的資金。該地區的消費者對永續和無動物實驗的蛋白質持開放態度,這促使餐廳和特色零售商探索新產品的推出。監管機構已開始修訂安全和標籤框架,增強了生產商的信心。憑藉著經驗豐富的人才、成熟的Start-Ups網路和良好的投資環境,北美將繼續引領市場成長和技術進步。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於市場對價格合理、安全清潔蛋白質的需求不斷成長。許多國家面臨土地資源有限和對水產品高度依賴的困境,這推動了對培養肉替代品的投資。新加坡、中國、日本和韓國等國政府正在資助研究計畫、提供津貼並支持監管流程,以增強食品安全。核准的加速和餐廳產品的上市提高了市場認知度和消費者興趣。快速的都市化、永續性目標以及Start-Ups企業的積極湧入,都促進了亞太地區的強勁成長。因此,亞太地區正在崛起為最具活力且成長最快的區域市場。
According to Stratistics MRC, the Global Cell-Cultured Meat & Seafood Market is accounted for $393.82 million in 2025 and is expected to reach $3354.25 million by 2032 growing at a CAGR of 35.8% during the forecast period. Cell-cultured meat & seafood involves creating real meat directly from living animal cells, cultivated under clean, controlled laboratory or industrial conditions. Instead of raising livestock or catching fish, cells grow into muscle and fat tissues that replicate traditional flavors, nutrients, and culinary experience. This innovative approach addresses major concerns around climate impact, antibiotic resistance, animal welfare, and resource depletion from global fisheries. Use of bioreactors, engineered growth factors, and efficient cell-culturing systems supports consistent production without seasonal or geographical constraints. With rising interest in sustainable proteins, startups and major food companies are investing heavily. Enhanced automation, cheaper media, and supportive regulations are gradually paving the path toward commercial viability.
According to the Journal of Biological Engineering (2024), cell-cultivated seafood production is a viable alternative to meet rising global demand for fish protein, which currently accounts for 17% of total animal protein consumption. With 90% of marine fish stocks fished at or above sustainable levels, cellular aquaculture offers a sustainable solution.
Rising demand for sustainable protein
Environmental sustainability has become a powerful catalyst for the expansion of the cell-cultured meat & seafood industry. Conventional livestock and marine harvesting contribute to rising emissions, habitat loss, water contamination, and overfishing. In contrast, cultured protein can be produced with minimal land, reduced water inputs, and sharply lower carbon output. This technology appeals to climate-conscious consumers, businesses, and policymakers aiming to adopt greener food systems. With international commitments to sustainability and carbon reduction, governments and investors are funding innovation in bioreactors, growth media, and scalable production plants. As awareness of ecological damage intensifies, demand for clean and responsible protein sources strengthens, boosting market progress.
High production costs and limited scalability
A major limitation hindering market expansion is the expensive and technically complex production process. Cultured meat depends on costly growth factors, cell lines, industrial bioreactors, and controlled facilities that significantly increase operating expenses. The industry also requires expert scientists and engineers, raising labor costs. Although new methods are reducing expenses, many countries lack the required biomanufacturing infrastructure for mass production. Commercial-scale output is still difficult, causing retail prices to remain higher than traditional animal protein. Without cheaper inputs, streamlined processes, and strong supply chains, cultured products will continue to appear mainly in small trials and specialized outlets rather than widespread grocery markets.
Advancements in bioprocessing and cost reduction
Ongoing technological progress is creating strong commercial advantages for cultured meat manufacturers. Enhanced media formulations, optimized bioreactors, and cost-efficient scaffolds are reducing reliance on costly ingredients and lowering operational budgets. Automation, robotics, and digital monitoring streamline production steps, improving uniformity, safety, and flavor replication. Research institutes and startups are designing scalable workflows that enable higher cell yields and improved texture at reduced cost. As manufacturing systems upgrade, retail pricing can gradually approach that of conventional meat. Collaborations with major food companies, universities, and ingredient suppliers help build global supply networks. These advancements make cultured proteins more competitive and widely available.
Competition from plant-based and traditional meat
Cultured meat firms operate in a highly competitive landscape where plant-based and conventional meat products dominate shelf space. Plant-based brands benefit from mass production, lower pricing, and strong consumer recognition, making them easier to purchase. At the same time, traditional meat is affordable, well-accepted, and supported by large farming industries. If lab-grown products cannot match cost, flavor familiarity, or accessibility, buyers may continue choosing existing protein sources. Large meat corporations are also improving sustainability standards and advertising eco-friendly practices, reducing the urgency to switch. Such competition may restrict growth prospects for cultured meat and delay mainstream acceptance.
COVID-19 created both obstacles and opportunities for the cultured meat sector. Conventional meat production faced supply shortages, contamination risks, and temporary facility closures, prompting consumers to consider safer, hygienic protein sources. This shift encouraged greater funding and policy attention toward lab-grown meat and seafood. On the other hand, travel restrictions and laboratory shutdowns slowed experimental trials, equipment delivery, and scaling projects. Some startups struggled with higher operating expenses and limited investor confidence early in the pandemic. Yet, the situation highlighted the advantages of controlled, disease-free manufacturing systems. As a result, cultured meat gained long-term visibility as a resilient and secure food solution.
The poultry segment is expected to be the largest during the forecast period
The poultry segment is expected to account for the largest market share during the forecast period because chicken is a popular, versatile protein consumed across regions. Cultured poultry cells grow efficiently and require fewer engineering challenges than more complex meats, enabling smoother scale-up and product consistency. Many emerging companies are launching chicken-based prototypes such as bites, strips, and blended formats that fit existing menus and cooking methods. The segment gains additional momentum from nutrition-aware customers seeking lighter animal protein alternatives. Food brands and quick-service outlets show greater willingness to trial cultured chicken, which supports faster commercialization and mainstream visibility. As a result, poultry stays ahead of other cultured meat categories.
The pet food segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pet food segment is predicted to witness the highest growth rate, driven by consumer interest in healthier, safer nutrition for pets. Many owners are shifting away from conventional by-products and unknown meat sources, preferring transparent, cruelty-free ingredients. Cultured protein eliminates contamination risks and avoids antibiotics, providing a premium alternative that aligns with rising pet humanization trends. Numerous innovators are formulating cell-cultured meals and treats for dogs and cats, helping the category expand quickly. Because approval processes for animal food can be simpler than human products, companies can launch earlier and reach the market faster, supporting strong CAGR potential.
During the forecast period, the North America region is expected to hold the largest market share because of its strong scientific ecosystem, supportive innovation culture, and early commercialization activity. Research laboratories and pioneering food-tech companies are rapidly advancing cell lines, bioreactors, and hybrid product formats, attracting substantial funding from investors. Consumers in the region are open to sustainable and cruelty-free proteins, motivating restaurants and specialty retailers to test new product launches. Regulatory bodies have begun reviewing safety and labeling frameworks, boosting confidence among producers. With access to experienced talent, mature startup networks, and favorable investment conditions, North America continues to lead market growth and technological progress.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to increasing demand for affordable, safe, and clean protein. Many nations face limited land availability and heavy reliance on seafood, motivating investment in lab-grown alternatives. Governments in Singapore, China, Japan, and South Korea are funding research programs, offering grants, and supporting regulatory pathways to strengthen food security. Early approvals and restaurant-level product launches are improving market awareness and consumer interest. Rapid urban lifestyles, sustainability goals, and active startup participation contribute to strong expansion. As a result, Asia-Pacific is emerging as the most dynamic and fast-growing regional market.
Key players in the market
Some of the key players in Cell-Cultured Meat & Seafood Market include Shiok Meats Inc, Finless Foods, Inc., CULT Food Science Corp., Future Meat Technologies Ltd., Bene Meat Technologies, Forged by Vow Group Pty Ltd., Aleph Farms Ltd., Innocent Meat GmbH, Gourmey, Avant Meats Company Limited, Meatable B.V., Orbillion Bio, Inc., Neat Meatt Biotech Private Limited, BlueNalu, Inc. and LabFarm Sp. z o.o.
In October 2025, CULT Food Science Corp. announces that it has entered into a debt settlement agreement with an arm's-length creditor to settle outstanding indebtedness totaling $132,500. Pursuant to the Debt Settlement, the Company will issue an aggregate of 8,833,333 common shares at a deemed price of $0.015 per Share, representing the Company's 20-day volume-weighted average price.
In September 2025, BeneMeat has launched its Try & Share Program, offering EU citizens the opportunity to test dog treats containing cultivated meat while providing feedback on the products. The program represents the first consumer trial of cultivated meat products for pets in the European market.
In August 2022, Mirai Foods and Shiok Meats have entered into a strategic partnership agreement. The collaboration will enable the two innovators to exchange know-how and supplies to bring cultivated beef to Singapore. MIRAI FOODS will supply Gaia Foods with its one-of-a-kind bovine muscle and fat stem cells - the essential raw material for producing cultivated beef.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.